Figure 2
Figure 2. Characterization of BM-derived WT and BLT1/2−/− DCs. (A) FACS analysis of membrane phenotype in WT and BLT1/2−/− DCs. Gray line indicates isotype control; broken line, iDCs; and black line, mDCs. (B) FITC-dextran uptake. (C) Mixed leukocyte reaction induced by WT and BLT1/2−/− DCs. (D,E) Calcium mobilization measurement in response to LTB4 in WT (D) and in BLT1/2−/− (E) DCs. (F, G) In vitro chemotaxis of iDCs (F) and mDCs (G) toward CCL3 (100 ng/mL), CCL19 (100 ng/mL), and LTB4 (100 nM). Error bars indicate SE.

Characterization of BM-derived WT and BLT1/2−/− DCs. (A) FACS analysis of membrane phenotype in WT and BLT1/2−/− DCs. Gray line indicates isotype control; broken line, iDCs; and black line, mDCs. (B) FITC-dextran uptake. (C) Mixed leukocyte reaction induced by WT and BLT1/2−/− DCs. (D,E) Calcium mobilization measurement in response to LTB4 in WT (D) and in BLT1/2−/− (E) DCs. (F, G) In vitro chemotaxis of iDCs (F) and mDCs (G) toward CCL3 (100 ng/mL), CCL19 (100 ng/mL), and LTB4 (100 nM). Error bars indicate SE.

Close Modal

or Create an Account

Close Modal
Close Modal